Assignee
AMYLIN PHARMACEUTICALS LLC
US9 patents
Top patents by PatentIndex Score
US8906851B2Dec 9, 2014
Method for treating diabetes
AMYLIN PHARMACEUTICALS LLC17 citations89
US8603761B2Dec 10, 2013
GLP-1 receptor agonist bioassay
AMYLIN PHARMACEUTICALS LLC14 citations78
US8951962B2Feb 10, 2015
Modified exendins and exendin agonists
AMYLIN PHARMACEUTICALS LLC4 citations76
US9593154B2Mar 14, 2017
Engineered polypeptides having enhanced duration of action
AMYLIN PHARMACEUTICALS LLC4 citations68
US9453063B2Sep 27, 2016
Hybrid polypeptides with selectable properties
AMYLIN PHARMACEUTICALS LLC0 citations51
US9133260B2Sep 15, 2015
GIP analog and hybrid polypeptides with selectable properties
AMYLIN PHARMACEUTICALS LLC1 citations51
US8906849B2Dec 9, 2014
Pancreatic polypeptide family motifs, polypeptides and methods comprising the same
AMYLIN PHARMACEUTICALS LLC0 citations50
US9884092B2Feb 6, 2018
Methods for treating diabetes and reducing body weight
AMYLIN PHARMACEUTICALS LLC0 citations49
US9034819B2May 19, 2015
Method of lowering cholesterol and triglycerides by administering exendins
AMYLIN PHARMACEUTICALS LLC0 citations49